The SP is still far from reflecting the fundamentals, but it's been moving in the right direction lately.
I think the reasons are:
* buyback sandbags (without spending a cent so far, a brilliant concept)
* tax loss selling finished after 30 June
* Gold Coast presentation new investors
* oh yes, there was a string of excellent preclinical announcements, but that would be the smallest effect.
The only thing worrying me is that patients should have been lined up waiting for the EMD AML trial to start in Newcastle, but apparently that's not the case. The hospital has been ready since the induction on 31 May. There aren't any competing EMD AML treatments, and those patients are excluded from other AML trials. So if they've applied for another clinical trial and been rejected, they would know they have EMD. I suspect lack of interest by oncologists. (But I have absolutely no evidence that oncologists own shares in hospices.)
RAC - Charts & Price Action, page-13032
-
- There are more pages in this discussion • 9,978 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
0.005(0.34%) |
Mkt cap ! $250.5M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.50 | $1.46 | $100.6K | 68.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8350 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 958 | 1 |
View Market Depth
| Last trade - 15.21pm 13/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |